MWC
ABBV icon

MBM Wealth Consultants’s AbbVie ABBV Stock Holding History

MBM Wealth Consultants’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Buy
12,001
+312
+3% +$67.1K 0.58% 25
2026
Q1 		$2.54M Buy
11,689
+270
+2% +$59.9K 0.58% 25
2025
Q4 		$2.61M Sell
11,419
-256
-2% -$58.3K 0.62% 24
2025
Q3 		$2.7M Sell
11,675
-14
-0.1% -$2.85K 0.67% 22
2025
Q2 		$2.17M Buy
11,689
+97
+0.8% +$18K 0.58% 25
2025
Q1 		$2.43M Buy
11,592
+246
+2% +$47.8K 0.72% 20
2024
Q4 		$2.04M Buy
11,346
+83
+0.7% +$15.3K 0.61% 23
2024
Q3 		$2.22M Sell
11,263
-133
-1% -$24.8K 0.7% 20
2024
Q2 		$1.91M Buy
11,396
+163
+1% +$27K 0.65% 21
2024
Q1 		$2.05M Sell
11,233
-68
-0.6% -$11.7K 0.72% 19
2023
Q4 		$1.85M Sell
11,301
-165
-1% -$24.1K 0.69% 20
2023
Q3 		$1.7M Buy
11,466
+108
+1% +$15.9K 0.74% 21
2023
Q2 		$1.53M Buy
11,358
+737
+7% +$108K 0.66% 23
2023
Q1 		$1.77M Hold
10,621
– – 0.72% 20
2022
Q4 		$1.73M Buy
10,621
+94
+0.9% +$14.4K 0.8% 19
2022
Q3 		$1.46M Buy
10,527
+472
+5% +$67.7K 0.7% 19
2022
Q2 		$1.54M Sell
10,055
-297
-3% -$45.4K 0.75% 20
2022
Q1 		$1.68M Buy
10,352
+20
+0.2% +$2.9K 0.7% 25
2021
Q4 		$1.4M Buy
10,332
+18
+0.2% +$2.13K 0.58% 27
2021
Q3 		$1.11M Sell
10,314
-14
-0.1% -$1.6K 0.51% 34
2021
Q2 		$1.16M Sell
10,328
-34
-0.3% -$3.83K 0.55% 32
2021
Q1 		$1.12M Sell
10,362
-488
-4% -$52.2K 0.57% 34
2020
Q4 		$1.16M Sell
10,850
-37
-0.3% -$3.56K 0.63% 28
2020
Q3 		$953K Sell
10,887
-127
-1% -$12K 0.61% 28
2020
Q2 		$1.08M Sell
11,014
-4,787
-30% -$421K 0.76% 25
2020
Q1 		$1.25M Sell
15,801
-157
-1% -$13.4K 1.03% 23
2019
Q4 		$1.41M Sell
15,958
-1,326
-8% -$110K 1.05% 26
2019
Q3 		$1.31M Buy
17,284
+194
+1% +$13.3K 1.03% 26
2019
Q2 		$1.26M Buy
17,090
+414
+2% +$32.5K 1.05% 26
2019
Q1 		$1.34M Buy
16,676
+342
+2% +$28K 1.18% 25
2018
Q4 		$1.51M Buy
+16,334
New +$1.44M 1.47% 21

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

MBM Wealth Consultants's ABBV Position: Q2 2026 in Review

MBM Wealth Consultants increased its AbbVie (ABBV) stake by 2.7% in Q2 2026, buying an estimated $67.1K and bringing the position to 12,001 shares worth $3.02M. The position accounts for 0.58% of the portfolio, ranked #25.

MBM Wealth Consultants first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 2,059 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MBM Wealth Consultants held 12,001 shares of AbbVie worth $3.02M as of Q2 2026.
  • MBM Wealth Consultants bought 312 AbbVie shares in Q2 2026, an estimated $67.1K.
  • AbbVie made up 0.58% of MBM Wealth Consultants's portfolio in Q2 2026, its #25 holding.
  • MBM Wealth Consultants first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
  • 2,059 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MBM Wealth Consultants's 13F filing for Q2 2026, filed 24 Jul 2026.